VANESSA PROCTER

Orphan Drug Act Medicaid Reform Drug Pricing Right to Try Third party payments for co-pays and premium assistance Medicare Part D coinsurance

US Tax Reform Orphan Drug Tax Credit

Intellectual Property Issues

Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance Medicare Part D Coinsurance

PDUFA Reauthorization Right-to-Try Legislation RACE for Children Act

US Tax Reform Orphan Drug Tax Credit

Orphan Drug Act Drug Pricing ACA Repeal & Replace Right to Try Third party payments for co-pays and premium assistance RACE for Children Act CHIP

PDUFA Reauthorization Right-to-Try Legislation RACE for Children Act

US Tax Reform Orphan Drug Tax Credit

Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance

Intellectual Property Issues

US Tax Reform Orphan Drug Tax Credit

Orphan Drug Act Drug Pricing ACA Repeal & Replace Right to Try Third party payments for co-pays and premium assistance RACE for Children Act

Intellectual Property Issues

Medicare Inpatient Hospital Reimbursement Medicaid Reform Third party payments for co-pays and premium assistance

PDUFA Reauthorization Right-to-Try Legislation

US Tax Reform Orphan Drug Tax Credit

Drug Pricing Creates ACT (REMs) CURES Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues PDUFA

Corporate tax reform Orphan Drug Tax Credit Expiring tax provisions Patent Box

CMS Part B DEMO CMMI Medicaid Reform; Texas Medicaid Medicare Hospital Inpatient Payment Reform

CMS Part B DEMO Medicaid Reform; Texas Medicaid Medicare Hospital Inpatient Payment Reform

Drug Pricing Creates ACT (REMs) CURES Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues

Corporate tax reform Orphan Drug Tax Credit Expiring tax provisions

CMS Part B DEMO Medicaid Reform Medicare Hospital Inpatient Payment Reform

Creates ACT (REMs) Advancing Hope Act (PRV Reauthorization) ACA Implementation Issues Biosimilars Implementation

Corporate tax reform OD Tax Credit Expiring tax provisions

Corporate tax reform OD Tax Credit Expiring tax provisions

Patent Reform (Goodlatte; Coons bills)

TTP TTIP TPA

Patent Reform (Goodlatte; Coons bills)

TTP TTIP TPA

Corporate tax reform OD Tax Credit Expiring tax provisions

Corporate tax reform OD Tax Credit Expiring tax provisions

TTP TTIP TPA

ACA Implementation 21st Century Cures Initiative

Corporate tax reform OD Tax Credit Expiring tax provisions

Patent Reform (Goodlatte; Coons bills)

TTP TTIP TPA

Corporate tax reform OD Tax Credit Expiring tax provisions

Patent Reform (Goodlatte; Coons bills)

ACA Implementation 21st Century Cures Initiative

Corporate Tax Reform Proposals EXPIRE Act

21st Century Cures Initiative Biosimilars (BPCIA/ACA) Implementation

Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

Corporate Tax Reform Proposals EXPIRE Act

21st Century Cures Initiative Biosimilars (BPCIA/ACA) Implementation

ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton) Biosimilars

Tax Reform Act of 2014 (Chairman Camp Draft) Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act

Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

Tax Reform Act of 2014 (Chairman Camp Draft) Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act

ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton) Biosimilars

Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

ACA Implementation Issues 21st Century Cures Initiative (Chairman Upton)

Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Improvements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

Tax Reform Act of 2014 Corporate Tax Reform proposals Expiring Provisions Improvement Reform and Efficiency (EXPIRE) Act

Patent Reform: Schumer/Cornyn Compromise Draft Patent Transparency and Iprovements Act, S. 1720 Patent Abuse Reduction Act, S. 1013

Protecting Access to Medicare Act, HR 4302

ACA Implementation Issues

ACA Implementation issues, including health exchanges, biosimilars Track & Trace; pharmaceutical compounding Implementation legislation 340B issues Budget/Sequester issues impacting Medicare/Medicaid (SGR) and FDA user fees

Comprehensive Tax Reform proposals Patent Box proposals Orphan Drug Tax Credit R&D Tax Credit

Comprehensive tax reform proposals Patent Box proposals Orphan Drug Tax Credit

ACA Implementation issues, including health exchanges and biosimilars Track & Trace; pharmaceutical compounding legislation 340B Issues Budget/Debt limit issues impacting Medicare, Medicaid, the FDA and federal health systems

EU FTA

Comprehensive Tax Reform proposals (Camp; Baucus/Hatch) Patent Box Proposals (Feinstein/Schwartz) Orphan Drug Tax Credit

EU FTA

ACA Implementation issues (specialty tiering, health insurance exchanges) Track & Trace legislation (Burr & Harkin) Sequestration issues impacting Medicare, Medicaid, the FDA and federal health programs

Tax Reform Issues; Chairman Camp Draft Patent Box Draft proposals, Rep. Schwartz; Sen. Feinstein Tax Issues in Fiscal Cliff Legislation

Pre-Existing Condition Insurance Program (Upton, Burgess) Track & Trace Draft Legislation (Burr & Harkin) Health Insurance Exchanges under the ACA Sequestration and fiscal cliff issues impacting Medicare, Medicaid and federal health programs

2013 Sequestration and fiscal cliff issues impacting Medicare, Medicaid and federal health programs

Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein patent box draft Tax issues in fiscal cliff legislation

Camp Draft on tax reform Rep. Schwartz Patent Box draft Sen. Feinstein Patent Box draft

Food and Drug Administration Safety and Innovation Act (S. 3187) 2013 sequestration issues

Food and Drug Administration Safety and Innovation Act (S. 3187) Camp Draft on Tax Reform Rep. Schwartz Patent Box draft Senator Feinstein Patent Box draft

Prescription Drug User Fee (PDUFA) Reauthorization Pharmaceutical Supply Chain issues TREAT Act (S. 2113); FAST Act (H.R. 4132); ULTRA Act (H.R. 3737)